Colon Cancer Symptoms - Combining targeted therapy drugs may treat previously resistant tumors - Genetic Engineering News
Combining targeted therapy drugs may treat previously resistant tumors - Genetic Engineering News
A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches. In their Nature Medicine report, which is receiving early
Aggressive Cancer Treatment, Prevention Efforts Drop Cancer Rates - eMaxHealth.com
New cancer diagnosis rates decreased from 1999 to 2005 by 0.8% a year, according to a newly released report by the National Cancer Institute, the US Centers for Disease Control and the American Cancer Society. In addition, death rates from cancer
Genentech’s Avastin meets breast cancer study goal - Forbes
Genentech Inc. said Monday its blockbuster drug Avastin improved the survival time for breast cancer patients in a late-stage study, putting the drug closer to full regulatory approval to treat the condition. Avastin is already provisionally approved
Gene Test Could Predict Colon Cancer’s Return - BusinessWeek
TUESDAY, Nov. 25 (HealthDay News) — U.S. researchers say they’ve developed a genetic model for predicting the risk of recurrence in patients with early stage colon cancer. According to a team at the Duke Institute for Genome Science & Policy, the
Genomic signature of colon cancer may individualize treatment - PhysOrg
Researchers in the Duke Institute for Genome Sciences & Policy have developed a model for predicting risk of recurrence in early stage colon cancer patients, and have used the model to also predict sensitivity to chemotherapy and targeted therapy